141 results
S-3ASR
AUTL
Autolus Therapeutics plc
28 Mar 24
Automatic shelf registration
4:10pm
dividends or similar transactions.
Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(c) under
S-3ASR
EX-5.1
AUTL
Autolus Therapeutics plc
28 Mar 24
Automatic shelf registration
4:10pm
of this letter.
DOCUMENTS
For the purpose of issuing this letter, we have reviewed the following documents only:
a PDF copy of the Registration Statement … Agreement, (ii) proceed with preparation and filing with the SEC of the Registration Statement for the purpose of registering the Private Placement ADSs
S-3ASR
AUTL
Autolus Therapeutics plc
28 Mar 24
Automatic shelf registration
4:10pm
where action for that purpose is required, other than in the United States. Persons outside the United States who come into possession of this prospectus … days during each calendar quarter. Any trades that have as their principal purpose meeting this requirement will be disregarded. Our ADSs are listed
10-K
2023 FY
EX-10.12
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
solely for the purpose of financing does not constitute an Acquisition. 1.4 “Activity Enhancement Licensed IP” means the Activity Enhancement Licensed … to a Party, any Person that controls, is controlled by, or is under common control with that Party. For the purpose of this definition, “control” shall mean
10-K
2023 FY
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
hubs to meet projected near-, mid- and long-term commercial product requirements for commercialization. Our first purpose-built facility is located … interpreted the statute’s intent requirement to mean that if any one purpose of an arrangement involving remuneration is to induce referrals of federal
10-K
EX-97.1
z6xoyja9qs0v27jnak
21 Mar 24
Annual report
4:55pm
424B5
4a9pqu3y
9 Feb 24
Prospectus supplement for primary offering
5:15pm
8-K
EX-1.1
ko34bd 78260a
8 Feb 24
Autolus Announces Pricing of Underwritten Offering
4:17pm
8-K
EX-5.1
e1r2nek
8 Feb 24
Autolus Announces Pricing of Underwritten Offering
4:17pm
8-K
EX-10.1
pl1lg
8 Feb 24
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
6:06am
8-K
EX-10.3
xlfwuyan14sqx6l53
8 Feb 24
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
6:06am
8-K
EX-10.2
oey89p4 gc48ru3i
8 Feb 24
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
6:06am
S-3ASR
EX-5.1
y6ap0wu
7 Feb 24
Automatic shelf registration
10:00pm
S-3ASR
arn6hu5yyw596xos
7 Feb 24
Automatic shelf registration
10:00pm
S-3ASR
EX-4.7
x8wlja 4ixdjjlpb
7 Feb 24
Automatic shelf registration
10:00pm
S-3ASR
EX-4.9
3rkn9tggxv26xd m37x
7 Feb 24
Automatic shelf registration
10:00pm
S-3ASR
EX-4.10
19p05lddox 0bw
7 Feb 24
Automatic shelf registration
10:00pm
10-Q
EX-10.2
w3fk1n
9 Nov 23
Quarterly report
4:18pm
10-Q
EX-10.1
vy2fpekl7bxweabvdmh
9 Nov 23
Quarterly report
4:18pm
S-8
p6s0jbatmco7tiu5
3 Nov 23
Registration of securities for employees
4:02pm